Participants 44 102 7
menopausal symptoms in women treated with soy isoflavones.
Participants 159 247 4
menopausal symptoms in women who do and who do not produce equol, a daidzein metabolite.
Participants 255 378 8
A randomized, double-blind, placebo-controlled clinical trial was conducted over 6 months with 96 healthy menopausal women.
Participants 437 588 3
the women in the study group were assigned to the equol-producing (EP) or the non-EP group according to the presence or absence of equol in their urine
Participants 922 1026 3
Isoflavone supplementation improves menopausal symptoms only in women with the ability to produce equol.
